Dr Agarwal's Eye

Market Cap: Small Cap
Industry: Hospital
ISIN: INE934C01018
NSEID:
BSEID: 526783

INR

5,503.00

13.8 (0.25%)

BSENSE

Dec 18

BSE+NSE Vol: 507

{
  "main_header": {
    "sid": 718153,
    "name": "Dr Agarwal's Eye",
    "stock_name": "Dr Agarwal's Eye",
    "full_name": "Dr Agarwals Eye Hospital Ltd",
    "name_url": "stocks-analysis/dr-agarwal-s-eye",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,503.00",
    "chg": 13.8,
    "chgp": "0.25%",
    "dir": 1,
    "prev_price": "5,489.20",
    "mcapval": "2,643.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 526783,
    "symbol": "",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE934C01018",
    "curr_date": "Dec 18",
    "curr_time": "",
    "bse_nse_vol": "507 ",
    "exc_status": "Active",
    "traded_date": "Dec 18, 2025",
    "traded_date_str": "2025 12 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-agarwal-s-eye-718153-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Dr Agarwal's Eye falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dr-agarwals-eye-fallingrising-3752215",
        "imagepath": "",
        "date": "2025-12-09 00:38:44",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance and Market Context</strong></p>\n<p>The stock has been under pressure for the past five consecutive trading sessions, resulting in a cumulative loss of 6.65% over the last week. This decline notably outpaces the benchmark Sensex’s modest 0.63% fall during the same period, signalling a relative underperformance. Despite this short-term weakness, the stock has delivered a positive return of 3.12% over the past month, slightly outperforming the Sensex’s 2.27% gain, indicating some resilience in recent weeks.</p>\n<p>However, the year-to-date (YTD) performance paints a more challenging picture for investors, with Dr Agarwal's Eye Hospital Ltd down by 12.26%, contrasting sharply with the Sensex’s robust 8.91% rise. Similarly, over the last one year, the stock has declined b..."
      },
      {
        "title": "Dr Agarwal's Eye Sees Positive Shift in Market Evaluation Amid Strong Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dr-agarwals-eye-upgraded-from-sell-to-hold-by-marketsmojo-on-29-aug-2025-3736978",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DrAgarwalsEye_mojoScore_3736978.png",
        "date": "2025-11-29 17:52:00",
        "description": "Dr Agarwal's Eye has experienced a notable revision in its market evaluation, reflecting a more favourable analytical perspective. This shift is underpinned by a combination of robust financial trends, technical momentum, and valuation considerations within the hospital sector."
      },
      {
        "title": "Is Dr Agarwal's Eye overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-dr-agarwals-eye-overvalued-or-undervalued-3734527",
        "imagepath": "",
        "date": "2025-11-28 08:13:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Valuation Metrics and What They Indicate</strong></p>\n<p>At the heart of any valuation analysis lies the price-to-earnings (PE) ratio, which for Dr Agarwal's Eye stands at 41.45. This figure is significantly higher than the broader market average and indicates that investors are willing to pay a steep premium for each rupee of earnings. Complementing this, the price-to-book (P/B) ratio of 8.30 further underscores the market's elevated expectations, suggesting that the stock is trading well above its net asset value.</p>\n<p>Enterprise value multiples also paint a similar picture. The EV to EBIT ratio is nearly 31, while the EV to EBITDA ratio is above 21, both of which are considerably high for the hospital sector. These multiples imply that the market anticipates robust future earnings growt..."
      },
      {
        "title": "Dr Agarwals Eye Hospital Valuation Shifts Highlight Changing Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-agarwals-eye-hospital-valuation-shifts-signal-changing-market-sentiment-3734555",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DrAgarwalsEyeHo_valuationdot_3734555.png",
        "date": "2025-11-28 08:00:37",
        "description": "Dr Agarwals Eye Hospital has experienced notable shifts in its valuation parameters, reflecting evolving market perceptions within the hospital sector. Recent data reveals adjustments in key metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV), positioning the stock in a different valuation category compared to its historical averages and peer group."
      },
      {
        "title": "Dr Agarwals Eye Hospital Hits Intraday High with Strong 7.44% Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-agarwals-eye-hospital-hits-intraday-high-with-716-surge-on-27-nov-2025-3733719",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DrAgarwalsEyeHo_priceRelatedfactors_3733719.png",
        "date": "2025-11-27 13:07:21",
        "description": "Dr Agarwals Eye Hospital demonstrated robust intraday performance on 27 Nov 2025, reaching an intraday high of Rs 5,539.95, reflecting a 7.44% rise from the previous close. The stock outpaced its sector and broader market indices, marking a notable rebound after a sequence of declines."
      },
      {
        "title": "Dr Agarwals Eye Hospital Sees Shift in Technical Momentum Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-agarwals-eye-hospital-technical-momentum-shifts-signal-bullish-outlook-3730290",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DrAgarwalsEyeHo_technicaldot_3730290.png",
        "date": "2025-11-26 08:05:55",
        "description": "Dr Agarwals Eye Hospital's stock has experienced a notable shift in technical momentum, reflecting a complex interplay of bullish and bearish signals across various timeframes. While daily moving averages indicate a positive trend, monthly indicators present a more cautious outlook, underscoring the nuanced market assessment of this hospital sector player."
      },
      {
        "title": "Dr Agarwals Eye Hospital Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-agarwals-eye-hospital-technical-momentum-shifts-amid-mixed-market-signals-3723822",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DrAgarwalsEyeHo_technicaldot_3723822.png",
        "date": "2025-11-24 08:03:34",
        "description": "Dr Agarwals Eye Hospital's stock has experienced a nuanced shift in price momentum, reflecting a complex interplay of technical indicators across multiple timeframes. Recent evaluation adjustments highlight a transition from a bullish to a mildly bullish trend, with key metrics such as MACD, RSI, and moving averages offering a varied outlook for investors navigating the hospital sector."
      },
      {
        "title": "Is Dr Agarwal's Eye technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-dr-agarwals-eye-technically-bullish-or-bearish-3713878",
        "imagepath": "",
        "date": "2025-11-19 08:15:03",
        "description": "As of 18 November 2025, the technical trend has changed from mildly bullish to bullish. The current technical stance is bullish with moderate strength. Key indicators driving this stance include a bullish MACD on the weekly timeframe, bullish Bollinger Bands on both weekly and monthly timeframes, and bullish moving averages on the daily timeframe. However, the monthly MACD and KST are mildly bearish, indicating some caution. The RSI shows a bullish signal on the monthly but no signal on the weekly. Overall, while there are mixed signals in the longer-term indicators, the prevailing trend is bullish...."
      },
      {
        "title": "Dr Agarwals Eye Hospital Technical Momentum Shifts Signal Market Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-agarwals-eye-hospital-technical-momentum-shifts-signal-bullish-outlook-3714282",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DrAgarwalsEyeHo_technicaldot_3714282.png",
        "date": "2025-11-19 08:07:06",
        "description": "Dr Agarwals Eye Hospital has exhibited a notable shift in its technical parameters, reflecting a change in price momentum and market sentiment. The stock, currently priced at ₹5,250.00, shows a mild bullish trend on weekly charts and a more pronounced bullish stance on daily moving averages, signalling evolving investor interest within the hospital sector."
      }
    ],
    "total": 272,
    "sid": "718153",
    "stock_news_url": "https://www.marketsmojo.com/news/dr-agarwals-eye-hospital-718153"
  },
  "announcements": [
    {
      "caption": "Corporate Action-Board approves Dividend",
      "datetime": "30-Oct-2025",
      "details": "Approval of Interim Dividend of Rs.3 per equity share for the financial year 2025-26.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 And Declaration Of Interim Dividend",
      "datetime": "30-Oct-2025",
      "details": "As per letter enclosed.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025",
      "datetime": "30-Oct-2025",
      "details": "As per the letter enclosed.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dr Agarwals Eye Hospital Ltd has declared <strong>30%</strong> dividend, ex-date: 07 Nov 25",
          "dt": "2025-11-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Dr Agarwal's Eye falling/rising?

2025-12-09 00:38:44

Recent Price Performance and Market Context

The stock has been under pressure for the past five consecutive trading sessions, resulting in a cumulative loss of 6.65% over the last week. This decline notably outpaces the benchmark Sensex’s modest 0.63% fall during the same period, signalling a relative underperformance. Despite this short-term weakness, the stock has delivered a positive return of 3.12% over the past month, slightly outperforming the Sensex’s 2.27% gain, indicating some resilience in recent weeks.

However, the year-to-date (YTD) performance paints a more challenging picture for investors, with Dr Agarwal's Eye Hospital Ltd down by 12.26%, contrasting sharply with the Sensex’s robust 8.91% rise. Similarly, over the last one year, the stock has declined b...

Dr Agarwal's Eye Sees Positive Shift in Market Evaluation Amid Strong Financial Trends

2025-11-29 17:52:00

Dr Agarwal's Eye has experienced a notable revision in its market evaluation, reflecting a more favourable analytical perspective. This shift is underpinned by a combination of robust financial trends, technical momentum, and valuation considerations within the hospital sector.

Is Dr Agarwal's Eye overvalued or undervalued?

2025-11-28 08:13:19

Valuation Metrics and What They Indicate

At the heart of any valuation analysis lies the price-to-earnings (PE) ratio, which for Dr Agarwal's Eye stands at 41.45. This figure is significantly higher than the broader market average and indicates that investors are willing to pay a steep premium for each rupee of earnings. Complementing this, the price-to-book (P/B) ratio of 8.30 further underscores the market's elevated expectations, suggesting that the stock is trading well above its net asset value.

Enterprise value multiples also paint a similar picture. The EV to EBIT ratio is nearly 31, while the EV to EBITDA ratio is above 21, both of which are considerably high for the hospital sector. These multiples imply that the market anticipates robust future earnings growt...

Dr Agarwals Eye Hospital Valuation Shifts Highlight Changing Market Dynamics

2025-11-28 08:00:37

Dr Agarwals Eye Hospital has experienced notable shifts in its valuation parameters, reflecting evolving market perceptions within the hospital sector. Recent data reveals adjustments in key metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV), positioning the stock in a different valuation category compared to its historical averages and peer group.

Dr Agarwals Eye Hospital Hits Intraday High with Strong 7.44% Surge

2025-11-27 13:07:21

Dr Agarwals Eye Hospital demonstrated robust intraday performance on 27 Nov 2025, reaching an intraday high of Rs 5,539.95, reflecting a 7.44% rise from the previous close. The stock outpaced its sector and broader market indices, marking a notable rebound after a sequence of declines.

Dr Agarwals Eye Hospital Sees Shift in Technical Momentum Amid Mixed Market Signals

2025-11-26 08:05:55

Dr Agarwals Eye Hospital's stock has experienced a notable shift in technical momentum, reflecting a complex interplay of bullish and bearish signals across various timeframes. While daily moving averages indicate a positive trend, monthly indicators present a more cautious outlook, underscoring the nuanced market assessment of this hospital sector player.

Dr Agarwals Eye Hospital Sees Mixed Technical Signals Amid Price Momentum Shift

2025-11-24 08:03:34

Dr Agarwals Eye Hospital's stock has experienced a nuanced shift in price momentum, reflecting a complex interplay of technical indicators across multiple timeframes. Recent evaluation adjustments highlight a transition from a bullish to a mildly bullish trend, with key metrics such as MACD, RSI, and moving averages offering a varied outlook for investors navigating the hospital sector.

Is Dr Agarwal's Eye technically bullish or bearish?

2025-11-19 08:15:03

As of 18 November 2025, the technical trend has changed from mildly bullish to bullish. The current technical stance is bullish with moderate strength. Key indicators driving this stance include a bullish MACD on the weekly timeframe, bullish Bollinger Bands on both weekly and monthly timeframes, and bullish moving averages on the daily timeframe. However, the monthly MACD and KST are mildly bearish, indicating some caution. The RSI shows a bullish signal on the monthly but no signal on the weekly. Overall, while there are mixed signals in the longer-term indicators, the prevailing trend is bullish....

Dr Agarwals Eye Hospital Technical Momentum Shifts Signal Market Interest

2025-11-19 08:07:06

Dr Agarwals Eye Hospital has exhibited a notable shift in its technical parameters, reflecting a change in price momentum and market sentiment. The stock, currently priced at ₹5,250.00, shows a mild bullish trend on weekly charts and a more pronounced bullish stance on daily moving averages, signalling evolving investor interest within the hospital sector.